Boston Scientific Corp Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 253 trades in Boston Scientific Corp (NYSE: BSX) since 2014, across 24 members, worth an estimated $5.8M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 104 buys against 149 sells, a modestly sell-led skew, with Democratic members responsible for 53% of the trades and Republican members 47%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most BSX transactions among those shown, with 21. Other recent filers include Gilbert Cisneros, John Boozman, and Alan Armstrong. One notable disclosed move was a sale by Kevin Hern on October 28, 2025, down 50.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Boston Scientific Corp (BSX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Boston Scientific congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Aug 7, 2026 | Jul 20, 2026 | 18 days | BUY |  $1,001 - $15,000 | +13.91% | Spouse | |
Rohit Khanna House | Aug 7, 2026 | Jul 7, 2026 | 31 days | SELL | $1,001 - $15,000 | +10.07% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | BUY | $1,001 - $15,000 | +16.82% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | SELL | $1,001 - $15,000 | +6.27% | Spouse | |
 Gilbert Cisneros House | Jul 2, 2026 | Jun 5, 2026 | 27 days | BUY | $1,001 - $15,000 | +2.70% | Self | |
Gilbert Cisneros House | Jul 2, 2026 | Jun 5, 2026 | 27 days | SELL | $1,001 - $15,000 | +2.70% | Self | |
 John Boozman Senate | Jul 13, 2026 | Jun 4, 2026 | 39 days | SELL | $1,001 - $15,000 | +2.07% | Joint | |
Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | BUY | $1,001 - $15,000 | +4.57% | Child | |
Gilbert Cisneros House | Jun 8, 2026 | May 29, 2026 | 10 days | BUY | $1,001 - $15,000 | +3.21% | Self | |
Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | SELL | $1,001 - $15,000 | -1.19% | Spouse |
Boston Scientific (BSX) congressional trading FAQ
Can members of Congress legally trade Boston Scientific (BSX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Boston Scientific (BSX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Boston Scientific (BSX) trades public?
Yes. Every congressional trade in Boston Scientific (BSX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Boston Scientific (BSX)?
Members of Congress have disclosed 253 trades in Boston Scientific (BSX) worth $5.8M across 24 members, according to public STOCK Act filings.
Which members of Congress have traded Boston Scientific (BSX)?
Recent and active filers of Boston Scientific (BSX) disclosures include Rohit Khanna, Gilbert Cisneros, Lisa McClain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Boston Scientific (BSX) more?
Across disclosed Boston Scientific (BSX) trades, 53% were by Democrats and 47% by Republicans, led by Democrats (53%).
What is the most recent congressional Boston Scientific (BSX) trade?
The most recent disclosed Boston Scientific (BSX) trade was a sale by Rohit Khanna, filed Aug 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewBoston Scientific (BSX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.